Cytokine Levels Could Predict Immunotherapy Problems
Source: UT Southwestern University
Summary: Researchers at have identified blood-based biomarkers that may help identify those patients at greatest risk of developing autoimmune side effects from the treatment.
More Information: Shaheen Khan et al, “Immune dysregulation in cancer patients developing immune-related adverse events”, British Journal of Cancer (2018). DOI: 10.1038/s41416-018-0155-1